Nicholas F. Kuhn, PhD

Graduate Student
For Research Scientists
Research Programs
Research Areas
Inaccessible
Our Research Advantage

Nicholas F. Kuhn, PhD

Graduate Student
Share
Share
Nicholas F. Kuhn, BS, MS, Graduate Student

Email

[email protected]

Dissertation

Engineering Chimeric Antigen Receptor (CAR) T Cells to Elicit an Endogenous Antitumor Immune Response (2019)

Mentor

Renier Brentjens

Start Year

2014

End Year

2019

Education

BS, Julius Maximilian University of Würzburg; MS, Charité University Medicine Berlin

Science is a universal language that challenges reason, logic, and creativity. I have always been intrigued by the system and order that are inherent to science. I saw a PhD as a great opportunity to develop my scientific and professional skills and meet like-minded people with different ideas. Gerstner Sloan Kettering belongs to a great cancer biology institution and offers small classes and a tight-knit community. The straightforward curriculum also covers my interests — my research is on tumor immunology — and the numerous distractions in New York City are quite appealing!

Fellowships

Ruth L. Kirschstein Predoctoral Individual National Research Service Award (NIH F31) (2017-2019)

Geoffrey Beene Graduate Student Fellowship (2015-2016)

Publications

Kuhn NF, Lopez AV, Li X, Cai W, Daniyan AF, Brentjens RJ. (2020) CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function.Nat Commun. 11. 6171.

Kuhn NF, Purdon TJ, van Leeuwen DG, Lopez AV, Curran KJ, Daniyan AF, Brentjens RJ; (2019) CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.Cancer Cell. 35, 473-488. PMCID: PMC6428219.

Malandro N, Budhu S, Kuhn NF, Liu C, Murphy JT, Cortez C, Zhong H, Yang X, Rizzuto G, Altan-Bonnet G, Merghoub T, Wolchok JD. (2016)  Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion.  Immunity, 44, 179-93.

Berger A, Quast SA, Plötz M, Kuhn NF, Trefzer U, Eberle J. (2014) RAF Inhibition Overcomes Resistance to TRAIL-Induced Apoptosis in Melanoma Cells. J Invest Dermatol., 134, 430-40.

View a full listing of Nicholas F. Kuhn’s journal articles.